These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15093595)

  • 1. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol.
    Koizumi A; Fujii M; Kondoh M; Watanabe Y
    Eur J Pharm Biopharm; 2004 May; 57(3):473-8. PubMed ID: 15093595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of griseofulvin for topical application using N-methyl-2-pyrrolidone.
    Fujii M; Bouno M; Fujita S; Yoshida M; Watanabe Y; Matsumoto M
    Biol Pharm Bull; 2000 Nov; 23(11):1341-5. PubMed ID: 11085363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicokinetics and metabolism of N-[(14)C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption.
    Payan JP; Boudry I; Beydon D; Fabry JP; Grandclaude MC; Ferrari E; André JC
    Drug Metab Dispos; 2003 May; 31(5):659-69. PubMed ID: 12695356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport.
    Lee PJ; Langer R; Shastri VP
    J Pharm Sci; 2005 Apr; 94(4):912-7. PubMed ID: 15736187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An insight into the skin penetration enhancement mechanism of N-methylpyrrolidone.
    Cilurzo F; Vistoli G; Selmin F; Gennari CG; Musazzi UM; Franzé S; Lo Monte M; Minghetti P
    Mol Pharm; 2014 Mar; 11(3):1014-21. PubMed ID: 24446970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro release of tranilast from oily gels and penetration of the drug into Yucatan micropig skin.
    Hori N; Fujii M; Yamanouchi S; Miyagi M; Saito N; Matsumoto M
    Biol Pharm Bull; 1998 Mar; 21(3):300-3. PubMed ID: 9556165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone.
    Bader M; Keener SA; Wrbitzky R
    Int Arch Occup Environ Health; 2005 Sep; 78(8):673-6. PubMed ID: 16001206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
    Ligocka D; Lison D; Haufroid V
    Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of iontophoresis and permeation enhancers on the permeation of an acyclovir gel.
    Vaghani SS; Gurjar M; Singh S; Sureja S; Koradia S; Jivani NP; Patel MM
    Curr Drug Deliv; 2010 Oct; 7(4):329-33. PubMed ID: 20695844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of chemical enhancers in the transdermal delivery of lidocaine.
    Lee PJ; Ahmad N; Langer R; Mitragotri S; Prasad Shastri V
    Int J Pharm; 2006 Feb; 308(1-2):33-9. PubMed ID: 16321488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.
    Keener SA; Wrbitzky R; Bader M
    Int Arch Occup Environ Health; 2007 Feb; 80(4):327-34. PubMed ID: 16897094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation study of a patch containing propranolol by design of experiments.
    Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emulsion-Based Intradermal Delivery of Melittin in Rats.
    Han SM; Kim SG; Pak SC
    Molecules; 2017 May; 22(5):. PubMed ID: 28534835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human experimental exposure study on the uptake and urinary elimination of N-methyl-2-pyrrolidone (NMP) during simulated workplace conditions.
    Bader M; Wrbitzky R; Blaszkewicz M; van Thriel C
    Arch Toxicol; 2007 May; 81(5):335-46. PubMed ID: 17103143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of solvents on skin permeation of formoterol fumarate.
    Kakubari I; Nakamura N; Takayasu T; Yamauchi H; Takayama S; Takayama K
    Biol Pharm Bull; 2006 Jan; 29(1):146-9. PubMed ID: 16394528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of skin permeation of miconazole by phospholipid and dodecyl 2-(N,N-dimethyl amino)propionate (DDAIP).
    Fujii M; Büyüktimkin S; Büyüktimkin N; Rytting JH
    Int J Pharm; 2002 Mar; 234(1-2):121-8. PubMed ID: 11839443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human volunteer study on the inhalational and dermal absorption of N-methyl-2-pyrrolidone (NMP) from the vapour phase.
    Bader M; Wrbitzky R; Blaszkewicz M; Schäper M; van Thriel C
    Arch Toxicol; 2008 Jan; 82(1):13-20. PubMed ID: 17721780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Yucatan micropig skin for use as an in vitro model for skin permeation study.
    Fujii M; Yamanouchi S; Hori N; Iwanaga N; Kawaguchi N; Matsumoto M
    Biol Pharm Bull; 1997 Mar; 20(3):249-54. PubMed ID: 9084881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin.
    Suwanpidokkul N; Thongnopnua P; Umprayn K
    AAPS PharmSciTech; 2004 Aug; 5(3):e48. PubMed ID: 15760081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin.
    Singh I; Nair RS; Gan S; Cheong V; Morris A
    Pharm Dev Technol; 2019 Apr; 24(4):448-454. PubMed ID: 30084268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.